Related by context. All words. (Click for frequent words.) 71 ERBITUX 70 Taxotere R 69 Taxotere ® 69 HUMIRA 69 FOLOTYN 67 TYKERB 67 TORISEL 67 ACTEMRA 67 Rituxan 66 ZEVALIN 66 TYSABRI 66 ISENTRESS 66 eculizumab 66 FUZEON 66 relapsed multiple myeloma 66 Fludara 65 Vidaza 65 ofatumumab 65 monotherapy 65 romiplostim 65 rituximab 65 carfilzomib 65 Amrubicin 65 ABRAXANE 65 JANUVIA 64 vandetanib 64 Velcade 64 REVLIMID 64 MabThera 64 Afinitor 64 clofarabine 64 Dacogen 64 bendamustine 64 perifosine 64 sunitinib malate 64 SUTENT 64 panitumumab 64 azacitidine 64 XGEVA 64 vinorelbine 64 glufosfamide 63 INTELENCE 63 ixabepilone 63 PROMACTA 63 ENBREL 63 SIMPONI 63 dacarbazine 63 Tasigna 63 brentuximab vedotin 63 decitabine 63 telbivudine 63 PEGINTRON 63 DOXIL 63 CHOP chemotherapy 63 carboplatin paclitaxel 63 Cimzia ® 63 PEG INTRON 63 temozolomide 62 SPRYCEL 62 adalimumab 62 sunitinib 62 Nplate 62 ALIMTA 62 biologic therapy 62 VELCADE melphalan 62 Neulasta ® 62 REMICADE 62 MabCampath 62 APTIVUS r 62 ORENCIA R 62 CAELYX 62 docetaxel chemotherapy 62 Nexavar 62 Genasense 62 Clolar 62 Marqibo 62 CoFactor 62 valopicitabine 62 Treanda 62 bevacizumab 62 docetaxel 62 pemetrexed 62 Gemzar ® 62 Mylotarg 61 Xeloda 61 cetuximab 61 VIDAZA 61 AVONEX 61 Aclasta 61 HER2 positive metastatic breast 61 albinterferon alfa 2b 61 REYATAZ R 61 Vectibix 61 sorafenib 61 satraplatin 61 TEMODAL 61 TYZEKA 61 ganetespib 61 RG# [001] 61 VPRIV 61 BAY #-# 61 BEXXAR 61 Revlimid 61 posaconazole 61 irinotecan 61 oral anticoagulant 61 5 FU 61 REVLIMID ® 61 TMC# [001] 61 SEROQUEL 60 CIMZIA TM 60 IMGN# 60 bortezomib 60 capecitabine 60 RAPTIVA 60 Dacogen injection 60 TREANDA 60 REMICADE ® 60 picoplatin 60 TYGACIL 60 rilonacept 60 Tarceva 60 pegfilgrastim 60 NOXAFIL 60 FAMPYRA 60 eltrombopag 60 CANCIDAS 60 tipranavir 60 lapatinib 60 temsirolimus 60 FOLFIRI 60 GEMZAR 60 nab paclitaxel 60 chemotherapy regimens 60 trastuzumab 60 axitinib 60 metastatic CRC 60 carboplatin 60 Ventavis 60 PREZISTA r 60 lenalidomide Revlimid R 60 REVLIMID R 60 Aptivus ® 60 CIMZIA ™ 60 Targretin 60 anakinra 60 Trastuzumab 60 Femara 60 melphalan prednisone 60 MGCD# [001] 60 Rituximab 60 Ceplene 60 blinatumomab 60 ACTEMRA TM 60 elotuzumab 60 INTEGRILIN 60 metastatic colorectal cancer 60 PREZISTA 60 G CSF 60 AP# [003] 60 bevacizumab Avastin 60 YERVOY 59 pertuzumab 59 pralatrexate 59 RECOTHROM 59 Velcade bortezomib 59 TELCYTA 59 Cimzia R 59 Bortezomib 59 AGGRASTAT R 59 BiovaxID 59 PXD# 59 Phase Ib 59 mitoxantrone 59 tocilizumab 59 azathioprine 59 plus dexamethasone 59 FTY# 59 LEXIVA 59 Mozobil 59 methylnaltrexone 59 ONTAK 59 TRISENOX 59 OPAXIO 59 CIMZIA 59 sapacitabine 59 Tekamlo 59 tolerability 59 pomalidomide 59 SAPHRIS 59 lenalidomide 59 Increlex ® 59 INCB# [002] 59 Pemetrexed 59 Traficet EN 59 Perifosine 59 galiximab 59 imetelstat 59 ORENCIA 59 investigational compound 59 Hycamtin ® 59 Avastin 59 BYETTA 59 TRILIPIX 59 YONDELIS 59 sorafenib tablets 59 relapsed refractory multiple myeloma 59 Reolysin 59 standard chemotherapy regimen 59 Raptiva ® 59 chlorambucil 59 PEG Interferon lambda 59 FASLODEX 59 Nexavar ® 59 Multaq R 59 Arixtra 59 peg IFN 59 Locteron 59 AVASTIN 59 IRESSA 59 Abraxane 59 alvimopan 59 Betaferon ® 59 ZYVOX 59 nilotinib 59 RoACTEMRA 59 lapatinib Tykerb 59 CA4P 59 PRISTIQ 59 FOLFOX 59 gemcitabine 59 HuMax CD4 59 mycophenolate mofetil 59 everolimus 59 sorafenib Nexavar ® 59 REBETOL 59 Bevacizumab 59 plus prednisone 59 teduglutide 59 INC# 59 dasatinib 59 indolent NHL 59 etanercept 59 boosted protease inhibitor 59 abatacept 59 nitazoxanide 59 tanespimycin 59 palonosetron 59 relapsed SCLC 58 Ixempra 58 relapsing remitting multiple sclerosis 58 TAXOTERE R 58 Sandostatin LAR 58 Tavocept 58 CellCept 58 Vandetanib 58 rivaroxaban 58 telaprevir 58 APTIVUS 58 Torisel 58 RITUXAN 58 Onco TCS 58 VAPRISOL 58 Xcytrin 58 sorafenib Nexavar 58 refractory metastatic colorectal cancer 58 aflibercept 58 pegylated liposomal doxorubicin 58 THALOMID 58 dabigatran etexilate 58 ularitide 58 Tekturna HCT 58 relapsed refractory 58 Pegasys ® 58 NVA# 58 Noxafil 58 febuxostat 58 edoxaban 58 panitumumab Vectibix 58 FIRMAGON 58 AMITIZA 58 Amigal 58 COPAXONE R 58 Campath 58 Rituxan rituximab 58 Leukine 58 golimumab 58 teriflunomide 58 INCB# [001] 58 Clolar ® 58 Hycamtin 58 pegylated interferon 58 Azedra 58 LEUKINE 58 Panzem R NCD 58 Exforge 58 Actemra 58 certolizumab pegol 58 PROCRIT 58 tolvaptan 58 deforolimus 58 randomized Phase III 58 EOquin TM 58 Phase 1b 58 Eloxatin R 58 relapsing multiple sclerosis 58 Keppra ® 58 Tarceva erlotinib 58 HGS ETR1 58 Phase 2b clinical 58 EOquin 58 relapsed MM 58 PegIntron 58 aliskiren 58 rituximab Rituxan 58 STELARA 58 Imprime PGG 58 abiraterone acetate 58 daclizumab 58 confirmatory Phase III 58 docetaxel Taxotere ® 58 erlotinib 58 Exjade 58 Jevtana 58 belinostat 58 cilengitide 58 obatoclax 58 Raptiva R 58 topotecan 58 ASA# 58 imatinib 58 LIALDA 58 IXEMPRA 58 ZETIA 58 MIRCERA 58 tivozanib 58 fenofibric acid 58 VYTORIN 58 visilizumab 58 Erbitux 58 Telaprevir 58 CD# antibody [001] 57 ARIKACE 57 enzastaurin 57 XIAFLEX 57 CYT# 57 Adalimumab 57 Taxotere docetaxel 57 Soliris 57 voreloxin 57 peginterferon alfa 2a Pegasys 57 letrozole Femara 57 ceftaroline 57 FOSRENOL 57 Bronchitol 57 gemcitabine chemotherapy 57 zalutumumab 57 amrubicin 57 ELACYT 57 Chemophase 57 vicriviroc 57 TREDAPTIVE 57 AZILECT 57 SEBIVO 57 fidaxomicin 57 oral deforolimus 57 FIRAZYR 57 docetaxel Taxotere R 57 tesmilifene 57 antithrombotics 57 REVLIMID lenalidomide 57 6R BH4 57 neratinib 57 QUADRAMET 57 ARCALYST 57 Sprycel 57 pitavastatin 57 NEXIUM 57 ONGLYZA 57 active comparator 57 SINGULAIR 57 plus gemcitabine 57 OncoVEX GM CSF 57 ELOXATIN 57 SYMBICORT 57 AZILECT R 57 BRIM2 57 ORENCIA ® 57 mg BID 57 RELISTOR 57 bortezomib Velcade R 57 Herceptin trastuzumab 57 fenofibrate 57 Diovan HCT 57 Everolimus 57 ARIMIDEX 57 TELINTRA 57 Revlimid lenalidomide 57 melphalan 57 cinacalcet 57 infliximab 57 HuMax EGFr 57 BROVANA 57 Phase 2b trial 57 sitagliptin 57 Alemtuzumab 57 Oxaliplatin 57 intravenous bisphosphonates 57 tamibarotene 57 CUBICIN 57 Azilect ® 57 Diabetic Macular Edema 57 PEGASYS 57 Tarceva TM 57 eniluracil 57 BARACLUDE R 57 denosumab 57 NUVIGIL 57 follicular NHL 57 administered subcutaneously 57 lixisenatide 57 Allovectin 7 ® 57 darunavir 57 HRPC 57 JAK inhibitor 57 bevacizumab Avastin ® 57 Taxotere 57 mRCC 57 platinum refractory 57 Carfilzomib 57 paclitaxel 57 gefitinib Iressa 57 Avastin bevacizumab 57 PRECiSE 57 gefitinib 57 Catena ® 57 trabectedin 57 irbesartan 57 subcutaneous formulation 57 dosing intervals 57 RAD# [003] 57 Doxil ® 57 FOLFOX6 57 Proxinium TM 57 PhosLo 57 seliciclib 57 diagnosed multiple myeloma 57 Vivaglobin 57 PROCRIT ® 57 VICTRELIS 57 Vaprisol 57 Rebif ® 57 metastatic renal cell carcinoma 57 JANUMET 57 Alpharadin 57 peginterferon alfa 57 tolerability profile 57 Laquinimod 57 indacaterol 57 ustekinumab 57 Etanercept 57 lupus nephritis 57 advanced NSCLC 56 mcg kg 56 Genasense ® 56 refractory Hodgkin lymphoma 56 Increlex R 56 adalimumab Humira 56 multiple myeloma 56 T DM1 56 placebo controlled clinical 56 ATACAND 56 anticancer therapy 56 AMPYRA 56 erlotinib Tarceva ® 56 dosing regimens 56 Dasatinib 56 PROLASTIN C 56 chronic lymphocytic leukemia CLL 56 ACZ# 56 HuMax CD# 56 Hepsera 56 zoledronic acid 56 NEUPOGEN 56 PEGINTRON TM 56 Pixantrone 56 raltegravir 56 ambrisentan 56 Gamunex 56 LUNESTA 56 tiotropium 56 trastuzumab Herceptin 56 phase Ib 56 AGILECT R 56 mCRC 56 atacicept 56 heavily pretreated patients 56 SELZENTRY 56 DAVANAT 56 B CLL 56 atypical antipsychotic 56 refractory multiple myeloma 56 pixantrone 56 oral rivaroxaban 56 Copegus ribavirin 56 Onbrez Breezhaler 56 CR# vcMMAE 56 ciclesonide 56 Victoza ® 56 mapatumumab 56 Cimzia TM 56 Cotara 56 ARIXTRA 56 angiotensin receptor blocker ARB 56 BARACLUDE 56 dosage regimens 56 COPAXONE ® 56 natalizumab 56 ADVEXIN 56 ® bortezomib 56 DASISION 56 ritonavir boosted 56 anti leukemic 56 QAB# 56 paclitaxel Taxol 56 REMINYL ® 56 LATUDA 56 VEGF Trap Eye 56 ThermoDox ® 56 AzaSite 56 forodesine 56 peginterferon alfa 2b 56 randomized Phase 56 RAPAFLO 56 SCH # 56 Victoza R 56 AZOR 56 Rebif R 56 PROVIGIL 56 Phase Ib clinical 56 recurrent ovarian cancer 56 lubiprostone 56 zileuton 56 dosing schedules 56 Zevalin 56 lintuzumab 56 ISTODAX 56 peginterferon alfa 2a 56 KOMBIGLYZE XR 56 Lantus ® 56 oral diclofenac 56 hematologic malignancies 56 lacosamide 56 AVANDIA 56 rFIXFc 56 ticagrelor 56 MabThera Rituxan 56 Irinotecan 56 Phase 2b study 56 levofloxacin 56 telmisartan 56 evaluating tivozanib 56 Aromasin 56 IMC A# 56 Gemcitabine 56 cetuximab Erbitux ® 56 Virulizin R 56 subcutaneously administered 56 MYCAMINE 56 efalizumab 56 Welchol 56 imatinib mesylate Gleevec 56 ZOSTAVAX 56 Navelbine ® 56 insulin detemir 56 elacytarabine 56 Telavancin 56 Xanafide 56 LEVADEX 56 pegylated interferon alfa 56 Tracleer R 56 acute coronary syndromes ACS 56 Rivaroxaban 56 FACTIVE 56 CYCLOSET 56 DAPT 56 motesanib 56 UPLYSO 56 Dapagliflozin 56 STELARA ™ 56 Zerenex 56 paliperidone palmitate 56 Aptivus 56 Certican 56 BENICAR 56 phase IIb clinical 56 temsirolimus Torisel ® 56 Camptosar ® 56 Thalomid ® 56 INTEGRILIN R eptifibatide Injection 56 Azixa 56 ULORIC 56 5-FU/LV 56 alpha 2a 56 phase IIb 56 Ribavirin 56 antithrombotic 56 XmAb# 56 Plenaxis TM 56 exenatide 56 acyclovir Lauriad R 56 Paraplatin ® 56 rNAPc2 56 MLN# 56 TNF antagonists 56 heavily pretreated 56 dacetuzumab 56 Plicera 56 WelChol 56 ezogabine 56 alvespimycin 56 AVELOX 55 VIMOVO 55 PEGASYS ® 55 protease inhibitor 55 romidepsin 55 Tamibarotene 55 metastatic hormone refractory 55 Metastatic Colorectal Cancer 55 Pegasys peginterferon alfa 2a 55 Halaven 55 Natalizumab 55 non squamous NSCLC 55 pivotal Phase III 55 DU #b 55 Naglazyme 55 LymphoStat B 55 sipuleucel T 55 ARCOXIA 55 angiographic outcomes 55 pegylated interferons 55 Satraplatin 55 oral FTY# 55 rilpivirine 55 cSSSI 55 ipilimumab 55 peginterferon 55 maraviroc 55 cytotoxic chemotherapy 55 FOLFOX4 55 valsartan 55 Synvisc One 55 MoxDuo IR 55 Evoltra ® 55 KAPIDEX 55 Navelbine 55 COMFORT II 55 AGGRASTAT ® 55 CVP chemotherapy 55 INTEGRILIN ® 55 Sandostatin LAR Depot 55 telavancin 55 non metastatic osteosarcoma 55 Rebetol 55 PRT# 55 evaluating Xcytrin 55 FUSILEV 55 AVINZA 55 belatacept 55 TAFA# 55 angiogenesis inhibitor 55 cytarabine 55 pazopanib 55 KRN# 55 Lantus R 55 Neulasta 55 REYATAZ ® 55 pegylated interferon alfa 2b 55 SEROQUEL XR 55 Golimumab 55 paliperidone ER 55 Zolinza 55 AVONEX ® 55 ramelteon 55 ZADAXIN 55 LY# [003] 55 EFAPROXYN 55 FOLPI 55 tacrolimus 55 hA# 55 Raptiva 55 Epoetin alfa 55 palifosfamide 55 certolizumab 55 dose escalation 55 EGFR expressing mCRC 55 glatiramer acetate 55 Eloxatin ® 55 placebo controlled Phase 55 linaclotide 55 ELND# 55 Icatibant 55 lymphoma CTCL 55 dasatinib Sprycel ® 55 regadenoson 55 DMARD 55 dose escalation trial 55 elesclomol 55 capecitabine Xeloda R 55 plus DOXIL 55 Rasilez Tekturna 55 celgosivir 55 Asentar 55 ponatinib 55 oral antiviral 55 Doxil 55 Hematide 55 cisplatin chemotherapy 55 ibandronate 55 canakinumab 55 Pentacel vaccine 55 tesetaxel 55 Newly Diagnosed Multiple Myeloma 55 SPRYCEL ® 55 Anturol 55 #mg/m# [001] 55 odanacatib 55 Firazyr 55 Rasilez 55 Besivance 55 antitumor activity 55 gemcitabine Gemzar 55 thalidomide Thalomid 55 ascending dose 55 pegloticase 55 AGILECT ® 55 acute PAO 55 ProSavin 55 Macroplastique 55 CRESTOR 55 Alocrest 55 Glivec 55 Afinitor ® 55 bosentan 55 Erlotinib 55 Promacta 55 ZOLINZA 55 AEGR 55 RAPAMUNE 55 idarubicin 55 Pirfenidone 55 Lialda 55 Inhalation Solution 55 EPZICOM 55 Emselex 55 Protelos 55 ascending doses 55 Cloretazine R VNP#M 55 fluorouracil 55 Elacytarabine 55 tacrolimus ointment 55 alemtuzumab 55 entecavir 55 brentuximab vedotin SGN 55 Valsartan 55 vidofludimus 55 Boceprevir 55 Feraheme 55 FOLOTYN ® 55 STELARA TM 55 Tygacil 55 Denosumab 55 Elidel 55 oxaliplatin 55 PREZISTA rtv 55 direct renin inhibitor 55 Targretin capsules 55 VEGF Trap 55 CTAP# Capsules 55 Omacetaxine 55 Cloretazine 55 Aloxi 55 ABRAXANE TM 55 LIVALO 55 bifeprunox 55 ARICEPT 55 TNF alpha inhibitor 55 pegylated interferon alfa 2a 55 myopathy rhabdomyolysis 55 proton pump inhibitor 55 alfa 2a 55 cyclophosphamide doxorubicin vincristine 55 infliximab Remicade 55 Femara letrozole 55 Lubiprostone 55 Rituxan MabThera 55 chemotherapeutic agent 55 Arzerra 55 tolerability profiles 55 sunitinib Sutent 55 AzaSite Plus 55 nimotuzumab 55 REYATAZ 55 Cethrin 55 huC# DM4 55 veltuzumab 55 registrational 55 Blinatumomab 55 talactoferrin 55 fosamprenavir 55 Phase III clinical 55 XIFAXAN 55 Phenoptin 55 INTUNIV 55 efficacy tolerability 55 DEXILANT 55 ocrelizumab 55 thymalfasin 55 chemotherapeutic regimen 55 interferon gamma 1b 55 superficial bladder cancer 55 NOXAFIL Oral Suspension 55 chemotherapy induced neutropenia 55 MGd 55 Aryplase 55 Quinamed 55 5 fluorouracil 55 prednisone prednisolone 55 interferon alfa 2b 54 ongoing Phase 1b 54 Vimpat ® 54 vorinostat 54 ABILIFY R 54 Vicinium TM 54 chemoradiotherapy 54 Camptosar 54 AZILECT ® 54 SNT MC# 54 Methylnaltrexone 54 cutaneous T cell 54 mcg albinterferon alfa 2b 54 Sycrest 54 abatacept Orencia 54 Riquent 54 Phase Ib study 54 immunosuppressant 54 investigational drug 54 ONGLYZA ™ 54 pivotal Phase 54 ABILIFY 54 Phase Ib II 54 Interferon beta 1a 54 refractory CTCL 54 gemcitabine carboplatin 54 Pertuzumab 54 IL# PE#QQR 54 iniparib 54 LEVAQUIN 54 chemoradiation 54 Pegintron 54 XYOTAX 54 GATTEX 54 epoetin 54 ProLindac 54 Vidaza azacitidine 54 lumiliximab 54 Nimotuzumab 54 PEG SN# 54 Fibrillex TM 54 Advexin 54 Ranexa 54 Hizentra 54 Bezielle 54 atrasentan 54 cangrelor 54 chronic angina 54 eszopiclone 54 estramustine 54 Peg IFN 54 cisplatin carboplatin 54 low dose cytarabine 54 Mepact 54 tgAAC# 54 xanthine oxidase inhibitor 54 antiretroviral agents 54 R bortezomib 54 dose regimens 54 Filgrastim 54 CYPHER ® Stent 54 Clevudine 54 ceftobiprole 54 entinostat 54 angiotensin II receptor blocker 54 custirsen 54 Exenatide 54 Aflibercept 54 Mipomersen 54 Ofatumumab 54 Sorafenib 54 adecatumumab 54 C1 INH 54 cabazitaxel 54 GARDASIL 54 CLARITY study 54 ACTOS 54 Phase 2a trial 54 ezetimibe simvastatin 54 vismodegib 54 Mycamine 54 BYDUREON 54 betrixaban 54 Docetaxel 54 Folfox 54 TAXUS Stent 54 AMEVIVE 54 Keppra R 54 FOSRENOL R 54 ofatumumab HuMax CD# 54 Tesetaxel 54 PLX# 54 Ceplene/IL-2 54 DORIBAX 54 Phase 1b trial 54 chemotherapeutic agents 54 omalizumab 54 relapsed ovarian cancer 54 placebo controlled Phase III 54 surrogate endpoint 54 Evoltra 54 lopinavir ritonavir 54 Cetuximab 54 octreotide LAR 54 Telintra 54 MEPACT 54 Hyphanox 54 miconazole Lauriad ® 54 elagolix 54 gemcitabine Gemzar ® 54 tamsulosin 54 HYCAMTIN 54 Ilaris 54 KETEK 54 retinal vein occlusion 54 COPEGUS 54 atazanavir sulfate 54 nesiritide 54 bortezomib Velcade ® 54 Ceftobiprole 54 Cladribine Tablets 54 Gleevec Glivec 54 Aeroquin 54 briakinumab 54 DexaSite 54 NUEDEXTA 54 eribulin 54 taxane 54 SUTENT ® 54 follicular lymphoma FL 54 docetaxel Taxotere 54 ABILIFY ® 54 phase IIa clinical 54 Platinol 54 Alimta 54 carvedilol 54 Frova ® 54 PRADAXA 54 Cimzia 54 Peginterferon 54 dose dexamethasone 54 Elotuzumab 54 plus ribavirin 54 everolimus tablets 54 Pfizer Sutent 54 ribavirin 54 Ozarelix 54 rindopepimut 54 pemetrexed Alimta 54 adult chronic ITP 54 dose cohorts 54 clodronate 54 Alinia 54 Gefitinib 54 ZACTIMA 54 FavId 54 mipomersen 54 Sutent 54 omacetaxine 54 HGS# 54 Eculizumab 54 FTY# fingolimod 54 anastrozole 54 registrational studies 54 prasugrel 54 rFVIIa 54 receptor tyrosine kinase inhibitor 54 HQK 54 Sym# 54 sorafenib Nexavar R 54 Cellegesic